ESPR.D

Esperion Therapeutics, Inc.

Pharmaceuticals · Pharmaceuticals

$204.21 sample

-3.24 (-1.56%) 1D

Market cap

$1.31T

Price as of

2026-10-24

Latest filing

8-K · 2026-10-14

Alerts

8

Price$204.21 +4.58% 3M daily closessample

209.66191.51

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider sell: EVP, Operations
Oct 14SEC8-K filed: material event
Oct 07INSInsider sell: 10% owner
Oct 02INSInsider buy: Chief Executive Officer
Sep 23INSInsider buy: Chief Executive Officer
Sep 15INSInsider sell: 10% owner
Sep 09INSInsider sell: Director
Aug 31INSInsider sell: EVP, Operations

Sign up to see the real ESPR.D record →

Company facts

SEC EDGAR registration

Name: Esperion Therapeutics, Inc.
Sector: Pharmaceuticals
Industry: Pharmaceuticals
Smart-money score: -9sample, -100 to +100
Reporting currency: USD

Who is positioning in ESPR.D

sample

Insiders: 26 insider transactions over 90 days, net selling, $83.8M
Congress: 1 members traded over 90 days
Institutions · 13F: 26 funds hold $10.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$40.9B +14.8% y/y

Q4 2024Q3 2026

Inventory$25.5B +9.0% y/y

Q4 2024Q3 2026

Accounts receivable$19.3B +20.6% y/y

Q4 2024Q3 2026

Total debt$51.4B +14.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.11T -12.8% 3M
Sample peer B: $1.21T +5.3% 3M
Sample peer C: $907.7B +10.3% 3M
Sample peer D: $1.28T -5.1% 3M
Sample peer E: $153.7B +10.3% 3M